Related Experiment Video
Updated: Feb 15, 2026

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
Structural basis for recognition of diverse antidepressants by the human serotonin transporter
Jonathan A Coleman1, Eric Gouaux2,3
1Vollum Institute, Oregon Health & Science University, Portland, OR, USA.
Abstract:
Selective serotonin reuptake inhibitors are clinically prescribed antidepressants that act by increasing the local concentrations of neurotransmitters at synapses and in extracellular spaces via blockade of the serotonin transporter. Here we report X-ray structures of engineered thermostable variants of the human serotonin transporter bound to the antidepressants sertraline, fluvoxamine, and paroxetine. The drugs prevent serotonin binding by occupying the central substrate-binding site and stabilizing the transporter in an outward-open conformation. These structures explain how residues within the central site orchestrate binding of chemically diverse inhibitors and mediate transporter drug selectivity.
More Related Videos
Related Concept Videos
Antidepressant Drugs: Overview
Short-distance Transport of Resources
Antidepressant Drugs: MAOIs and Other Agents
Regulated mRNA Transport
Facilitated Transport
Cell Diversity
Multicellular...

